Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Stake as of Sep 30, 2026 · Filed Nov 13, 2026
The holder reported owning less than 5%, which ends its duty to keep reporting this stake.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
Undefined
Compared with the manager's prior 13F
—
NaN
For the same quarter
Insider buying
Traded Nov 4 · filed 1 day later
A Vanda Pharmaceuticals director paid $13K out of pocket for Vanda Pharmaceuticals shares.
Insider buying
Traded Nov 5 · filed the same day
A Vanda Pharmaceuticals director paid $22K out of pocket for Vanda Pharmaceuticals shares. Shares held went up 6% with this purchase.
Insider buying
First insider buy since Aug 2025Traded Nov 3 · filed 2 days later
A Vanda Pharmaceuticals director paid $2.8K out of pocket for Vanda Pharmaceuticals shares. It was the first purchase in over a year.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.